Skip to content
etf.net

FAS vs PILL

Direxion Daily Financial Bull 3X ETF

FASANYSE Arca

Direxion Daily Pharmaceutical & Medical Bull 3X ETF

PILLDNYSE Arca

Overlap

Expense ratio

FAS −0.10pt a year

FAS0.88%PILL0.98%

Avg volume · 30D

FAS 6.7×the volume

FAS413KPILL61.4K

5Y return · a year

FAS +8.1pt

FAS+5.6%PILL−2.5%

FAS vs PILL Performance

Oct 29, 2021 – Oct 30, 2026

+31.4%FAS−11.9%PILL

Oct 29, 2021 to Oct 30, 2026. FAS +31.4%. PILL −11.9%. Use the arrow keys to read each point.−75%−50%50%Oct 2021Apr 2024Oct 2026
Expense ratio
FAS 0.88%, better
PILL 0.98%
Fund size
FAS $2.17B
PILL $16M
1Y total return
FAS +12.3%
PILL +71.9%, better
Yield (12M)
FAS 8.87%, better
PILL 0.39%
Holdings
FAS 87
PILL 68
Avg volume (30D)
FAS 413K sh, better
PILL 61.4K sh
NAV per share
FAS $168.18
PILL $15.61
52W range

ETF.net Grade

FAS: Cost 92, Risk 69, Mission not scored, Tradability 73, Holdings not scored, Durability 66. PILL: Cost 38, Risk 53, Mission not scored, Tradability 25, Holdings not scored, Durability 22.
Pillar letters and Scores for FAS, PILL, with each pillar’s weight
PillarFASPILL
Cost30% weightA92HigherD38
Mission25% weightNot scoredNot scored
Risk15% weightB69HigherC53
Tradability15% weightA73HigherD25
Holdings10% weightNot scoredNot scored
Durability5% weightB66HigherF22

Rank among 3x Leveraged Long funds

How we build Categories ›
Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. FAS and PILL are both graded against the same 30 3x Leveraged Long funds, so their Grades compare head to head.

3x Leveraged Long⁠

Category · 30 funds
See all 30 ›

FAS ranks 3rd and PILL 21st of 30 funds in the 3x Leveraged Long Category.

  1. Rank 1ATQQQProShares UltraPro QQQScore 86
  2. Rank 2AUDOWProShares UltraPro Dow30Score 81
  3. Rank 3AFASDirexion Daily Financial Bull 3X ETFScore 80
  4. Rank 4ASOXLDirexion Daily Semiconductor Bull 3X ETFScore 76
  5. Rank 20CTNADirexion Daily Small Cap Bull 3X ETFScore 41
  6. Rank 21DPILLDirexion Daily Pharmaceutical & Medical Bull 3X ETFScore 37
  7. Rank 22DEURLDirexion Daily FTSE Europe Bull 3X ETFScore 35

Our read on each fund

ETF.net Research

FASADirexion Daily Financial Bull 3X ETF

PILLDDirexion Daily Pharmaceutical & Medical Bull 3X ETF

In short

FAS Born in November 2008 with the banking system on fire, FAS aims to deliver three times the daily move of the Financial Select Sector Index. A one-day tool on roughly 80 financial stocks, built around a single-day objective.

PILL Three times the daily move of an equal-weight pharma index: not only Big Pharma, but the whole drug-development bench. 0.98% net of a waiver through September 1, 2027, and the daily reset makes it a trading tool.

Stated mandate

FAS The fund seeks a daily return equal to three times the performance of the Financial Select Sector Index, before fees and expenses. It is designed for a single-day objective rather than a multiple of the index’s cumulative return over longer periods.

PILL The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the S&P Pharmaceuticals Select Industry Index.

Why people hold it

  • FAS Launched in November 2008, into the crisis itself, and still one of the strongest implementations in its 3x peer group.
  • Costs 0.88% net of a waiver through September 1, 2027 (0.92% gross), below the median for 3x leveraged funds.
  • A multi-billion-dollar fund that trades steadily, so the leverage arrives in a reasonably liquid wrapper.
  • Straightforward plumbing: 3x the daily move of one named large-cap financials index, about 80 stocks, no stock-picking overlay.
  • PILL Rare pure-play leverage on drugmakers: 300% of the daily move of the S&P Pharmaceuticals Select Industry Index, while most 3x funds point at chips, banks or broad indexes.direxion.com
  • The index is modified equal weight, rebalanced quarterly, so a giant drugmaker and a small clinical-stage developer can sit at similar weights across about 50 holdings.spindices.comdirexion.com
  • Fee sits near the median for 3x funds: 0.98% net of a waiver through September 1, 2027, against a 1.22% gross ratio.
  • Trading since 2017, so there is a long public record of how the daily-reset math behaves through pharma booms and drawdowns.

Worth knowing

  • FAS The 3x goal resets every day. Hold longer and compounding can push results away from three times the index's move over that stretch, especially in choppy markets.
  • Leverage runs both directions: down days are magnified just as sharply, and this is one sector in one direction with no diversification cushion.
  • Not the cheapest 3x on the shelf: SOXL runs 0.75% and TQQQ 0.78%, each net of waivers through September 1, 2027 and September 30, 2027.
  • PILL Direxion's fact sheet is blunt: do not expect 3x the index over periods longer than a day. Choppy stretches can grind results down even if the index ends flat.direxion.com
  • Smaller and more thinly traded than category heavyweights like TQQQ and SOXL, so the spread is worth a look before you place an order.
  • Pricier than Direxion's 3x semiconductor sibling SOXL at 0.75% net of a waiver through September 1, 2027, and that fee applies to a position built for days, not years.direxion.com

Full FAS profile⁠

Full PILL profile⁠

FAS vs PILL Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

FAS vs PILL Cost

Overpaying PILL vs FAS

$1,657

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • FAS 0.88%

    $16,705

  • PILL 0.98%

    $18,362

$10,000
30 years

Cost over time

  • FAS 0.88%
  • PILL 0.98%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530PILL $18,362FAS $16,705

Year by year

YearFASPILLOverpaying
10$1,559$1,729$170
20$5,891$6,504$613
30$16,705$18,362$1,657

Expense ratio

  • 0.88%FAS, cheaper
  • 0.98%PILL
  • Middle half of 3x Leveraged Long funds
  • Median 0.96%

FAS 4th cheapest of 30 funds

PILL 18th cheapest of 30 funds

FAS vs PILL Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
FAS 8.87%, better
PILL 0.39%
Payout (12M)
FAS $14.62
PILL $0.06
Last payment
FAS $1.00
PILL $0.00094
Ex-dividend
FAS Sep 22, 2026
PILL Sep 22, 2026
Paid on
FAS Sep 29, 2026
PILL Sep 29, 2026
Frequency
FAS Quarterly
PILL Quarterly

Distribution history

Per share, 2017 to 2026, same scale for both

FASQuarterly · 36 paymentsAll FAS payments⁠
One bar per payment. 36 payments from 2017 to 2026 YTD. Dec 19, 2017 $0.08; Mar 20, 2018 $0.13; Jun 19, 2018 $0.16; Sep 25, 2018 $0.19; Dec 27, 2018 $0.16; Mar 19, 2019 $0.16; Jun 25, 2019 $0.17; Sep 24, 2019 $0.15; Dec 23, 2019 $0.11; Mar 24, 2020 $0.12; Jun 23, 2020 $0.04; Sep 22, 2020 $0.05; Dec 22, 2020 $0.08; Mar 23, 2021 $0.13; Jun 22, 2021 $0.14; Sep 21, 2021 $0.15; Dec 21, 2021 $0.36; Jun 22, 2022 $0.12; Sep 20, 2022 $0.22; Dec 20, 2022 $0.33; Mar 21, 2023 $0.17; Jun 21, 2023 $0.62; Sep 19, 2023 $0.29; Dec 21, 2023 $0.38; Mar 19, 2024 $0.36; Jun 25, 2024 $0.27; Sep 24, 2024 $0.32; Dec 23, 2024 $0.19; Mar 25, 2025 $0.46; Jun 24, 2025 $0.50; Sep 23, 2025 $0.39; Dec 10, 2025 $12.09; Dec 23, 2025 $0.39; Mar 24, 2026 $0.60; Jun 23, 2026 $0.53; Sep 22, 2026 $1.00. Use the arrow keys to read each point.$0$102017202020232026YTD
PILLQuarterly · 28 paymentsAll PILL payments⁠
One bar per payment. 28 payments from 2017 to 2026 YTD. Dec 19, 2017 $0.01; Jun 19, 2018 $0.05; Sep 25, 2018 $0.04; Dec 27, 2018 $0.10; Mar 19, 2019 $0.06; Jun 25, 2019 $0.02; Sep 24, 2019 $0.02; Dec 23, 2019 $0.00033; Dec 21, 2021 $0.00007; Mar 22, 2022 $0.0082; Jun 22, 2022 $0.0036; Sep 20, 2022 $0.02; Dec 20, 2022 $0.03; Mar 21, 2023 $0.02; Jun 21, 2023 $0.05; Sep 19, 2023 $0.04; Dec 21, 2023 $0.04; Mar 19, 2024 $0.03; Jun 25, 2024 $0.02; Sep 24, 2024 $0.03; Dec 23, 2024 $0.01; Mar 25, 2025 $0.02; Jun 24, 2025 $0.02; Sep 23, 2025 $0.0099; Dec 23, 2025 $0.03; Mar 24, 2026 $0.01; Jun 23, 2026 $0.02; Sep 22, 2026 $0.00094. Use the arrow keys to read each point.$0$102017202020232026YTD

FAS vs PILL Risk

Fall from peak · 5 years

  • FAS
  • PILL
Oct 29, 2021 to Oct 30, 2026. Worst fall: PILL −82.0% · Apr 2025. Use the arrow keys to read each point.−80%−60%−40%−20%0%Oct 2021Apr 2024Oct 2026

Risk facts

VolatilityStd dev, 3 years
FAS 46.3%, betterPILL 61.4%
Return per unit of riskSharpe ratio, 3 years
FAS 1.03, betterPILL 0.82
Worst fallMax drawdown, 5 years
FAS −66.9%, betterPILL −82.0%
Market sensitivityBeta, 5 years
FAS 2.63PILL 1.80

Popular comparisons

  • FASAvsTQQQA

    Direxion Daily Financial Bull 3X ETF · ProShares UltraPro QQQ

    Expense ratio
    0.88% · 0.78%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • PILLDvsTQQQA

    Direxion Daily Pharmaceutical & Medical Bull 3X ETF · ProShares UltraPro QQQ

    Expense ratio
    0.98% · 0.78%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • FASAvsUDOWA

    Direxion Daily Financial Bull 3X ETF · ProShares UltraPro Dow30

    Expense ratio
    0.88% · 0.94%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • PILLDvsUDOWA

    Direxion Daily Pharmaceutical & Medical Bull 3X ETF · ProShares UltraPro Dow30

    Expense ratio
    0.98% · 0.94%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • FASAvsSOXLA

    Direxion Daily Financial Bull 3X ETF · Direxion Daily Semiconductor Bull 3X ETF

    Expense ratio
    0.88% · 0.75%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • PILLDvsSOXLA

    Direxion Daily Pharmaceutical & Medical Bull 3X ETF · Direxion Daily Semiconductor Bull 3X ETF

    Expense ratio
    0.98% · 0.75%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.